Litcius/Paper detail

OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

Adrian G. Sacher, M.R. Patel, W.H. Miller, J. Desai, E. Garralda, Samantha E. Bowyer, T.W. Kim, M. De Miguel, A. Falcon, M.G. Krebs, James Lee, Mingwen Cheng, S.-W. Han, E. Shacham-Shmueli, M. Forster, G. Jerusalem, E. Massarelli, Luis Paz-Ares Rodríguez, H. Prenen, I. Walpole, K. Arbour, Yoonha Choi, N.V. Dharia, M. Lin, S. Mandlekar, S. Royer Joo, Zhe Shi, J. Schutzman, P. LoRusso

2022Journal of Thoracic Oncology21 citationsDOI

Topics & Concepts

MedicineKRASOncologyMutationInternal medicineLung cancerCancernon-small cell lung cancer (NSCLC)Cancer researchGeneticsColorectal cancerGeneA549 cellBiologyLung Cancer Treatments and MutationsCancer therapeutics and mechanismsLung Cancer Research Studies
OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation | Litcius